Three financial stories run alongside each other
The move from an illicit market to regulated commerce changes where sales occur, how businesses report them and which institutions collect revenue. It does not create a single measure of success. Legal-market turnover, company profit and shareholder return answer different questions.
A country can record rising legal sales while an individual producer loses money. A company can report more revenue while shareholders face dilution or a lower valuation. Reading cannabis economics well begins by keeping the market, the business and the security separate.
Canada provides a measurable legal-market example
Statistics Canada reported recreational cannabis sales of C$5.5 billion in the fiscal year ending March 2025, up 6.1 percent from the previous year. The figure covers provincial authorities and other retail outlets. It is a defined legal-sales measure, with a currency, period and distribution channel.
Health Canada’s 2024 Cannabis Survey offers a different perspective. Seventy-two percent of respondents who had used cannabis in the previous year reported a legal source as their usual source, compared with thirty-seven percent in 2019. The 2024 result was similar to seventy-three percent in 2023. This describes people’s reported usual source, not the proportion of every gram sold or every dollar spent. Together the measures show legal-channel development without proving that the illicit market has disappeared.
Revenue is not the amount left for owners
A company pays production, distribution, staffing, financing and other costs out of its revenue. Gross profit, operating result, cash flow and net profit therefore describe different stages of the business. A headline about sales cannot substitute for those accounts.
Tilray’s fiscal 2025 reporting provides a concrete historical example: total net revenue was about US$821 million, while the net loss was about US$2.18 billion. The company reported substantial impairment charges associated with goodwill and intangible assets from its 2021 combination. Such charges affect accounting profit differently from ordinary cash spending. The group also includes beverage, distribution and wellness activities, so its total revenue is not a pure cannabis-market figure.
A listed share adds another layer
A stock price reflects expectations about future business as well as current performance. Share issuance changes the number of claims on the business; borrowing creates obligations that must be considered alongside assets. A large addressable market alone tells neither how much of it a company will capture nor what margin it will retain.
This is why national legalisation headlines and individual share performance can move differently. Regulation creates conditions for a market, while management, competition, financing and valuation shape outcomes for a particular company.
Spain requires its own institutional comparison
Spain’s nonprofit association framework and its medical-cannabis framework should not be treated as equivalents of Canada’s adult-use retail market. Association law directs economic benefits towards organisational purposes rather than distributions to members. Medical preparations follow a separate clinical and pharmaceutical route.
Sources & further reading
General information, not individual legal or medical advice.